Table 3

Influence of chemotherapy on the detection of UP-II-positive cells in the blood of metastatic patients

Patient No.Sites of metastasisUP-II-positive cellsResponse to chemotherapy
8Lung+80% reduction
11Lymph nodes+87% reduction
53Liver, lymph nodes, bones+≥90% reduction for liver and lymph nodes, and 25–50% reduction for bony lesions
  • a All three patients underwent three or four cycles of cisplatin-based combination chemotherapy. Blood was collected at the term of the first cycle of the chemotherapy.